Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies
Saatheeyavaane Bhuvanendran(Monash University Malaysia), Mohd. Farooq Shaikh(University of Mumbai), Siti R. Yusof(Universiti Sains Malaysia), Nur Aziah Hanapi(Universiti Sains Malaysia), Iekhsan Othman(Monash University Malaysia), Nafees Ahemad(Monash University Malaysia)
Cited by 29
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Current strategies in extending half-lives of therapeutic proteins
|Journal of Controlled Release|2019|285
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity
|Frontiers in Microbiology|2015|178
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175